Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Delcath Systems, Inc.(DCTH) | 1,038,828 | 2,650,389 | +1,611,561 | $4.96M | $15.53M | 12.28% | +$10.57M |
| Myomo, Inc.(MYO) | 2,447,740 | 2,664,999 | +217,259 | $8.00M | $8.55M | 6.76% | +$550.5K |
| MediWound Ltd.SHS NEW(MDWD) | 485,990 | 513,490 | +27,500 | $6.93M | $7.97M | 6.30% | +$1.04M |
| Optinose Inc | 4,541,489 | 7,547,148 | +3,005,659 | $6.63M | $7.85M | 6.21% | +$1.22M |
| Abeona Therapeutics Inc.(ABEO) | 0 | 1,750,000 | +1,750,000 | $0 | $7.42M | 5.87% | +$7.42M |
| Xeris Biopharma Hldgs Inc | 2,820,170 | 3,120,170 | +300,000 | $6.23M | $7.02M | 5.55% | +$787.8K |
| Cellectar Biosciences, Inc.(CLRB) | 621,478 | 2,705,616 | +2,084,138 | $2.47M | $6.76M | 5.35% | +$4.29M |
| InspireMD, Inc.(NSPR) | 686,062 | 2,513,641 | +1,827,579 | $1.63M | $6.27M | 4.96% | +$4.65M |
| Cybin D/B/A Helus Pharma(HELP) | 13,960,000 | 19,300,000 | +5,340,000 | $5.77M | $5.23M | 4.14% | -$542.2K |
| Ocular Therapeutix, Inc.(OCUL) | 0 | 750,000 | +750,000 | $0 | $5.13M | 4.06% | +$5.13M |
| ABIVAX Société AnonymeADS(ABVX) | 378,416 | 378,416 | 0 | $5.41M | $5.00M | 3.96% | -$408.7K |
| Profound Medical Corp.(PROF) | 533,333 | 533,333 | 0 | $4.55M | $4.47M | 3.54% | -$74.7K |
| COMPASS Pathways plcADS(CMPS) | 734,000 | 734,000 | 0 | $6.11M | $4.43M | 3.51% | -$1.67M |
| Trevi Therapeutics, Inc.(TRVI) | 926,016 | 1,391,577 | +465,561 | $3.19M | $4.15M | 3.28% | +$952.1K |
| Kalvista Pharmaceuticals Inc | 287,985 | 337,985 | +50,000 | $3.42M | $3.98M | 3.15% | +$566.0K |
| Viridian Therapeutics, Inc.(VRDN) | 300,000 | 300,000 | 0 | $5.25M | $3.90M | 3.09% | -$1.35M |
| Verona Pharma PlcADS | 250,000 | 250,000 | 0 | $4.02M | $3.62M | 2.86% | -$407.5K |
| Clearside Biomedical Inc | 2,592,593 | 2,592,593 | 0 | $3.97M | $3.37M | 2.67% | -$596.3K |
| Outlook Therapeutics, Inc.(OTLK) | 311,775 | 450,000 | +138,225 | $3.72M | $3.32M | 2.63% | -$401.6K |
| Veru Inc.(VERU) | 4,500,000 | 2,696,003 | -1,803,997 | $3.15M | $2.27M | 1.79% | -$882.3K |
| PolyPid Ltd.(PYPD) | 415,800 | 416,800 | +1,000 | $1.91M | $1.79M | 1.42% | -$120.4K |
| Rezolute, Inc.(RZLT) | 200,000 | 250,000 | +50,000 | $510.0K | $1.07M | 0.85% | +$565.0K |
| Kiora Pharmaceuticals Inc | 2,300,000 | 255,555 | -2,044,445 | $1.62M | $1.07M | 0.85% | -$550.5K |
| Fortress Biotech, Inc.(FBIO) | 607,797 | 607,797 | 0 | $1.22M | $1.04M | 0.82% | -$176.3K |
| Geron Corporation(GERN) | 200,000 | 200,000 | 0 | $660.0K | $848.0K | 0.67% | +$188.0K |
| Unicycive Therapeutics Inc | 1,879,646 | 1,571,200 | -308,446 | $2.59M | $787.3K | 0.62% | -$1.81M |
| Spruce Biosciences Inc | 1,508,419 | 1,508,419 | 0 | $1.19M | $780.9K | 0.62% | -$404.6K |
| Talphera, Inc.(TLPH) | 758,966 | 758,966 | 0 | $781.7K | $675.5K | 0.53% | -$106.3K |
| Journey Medical Corporation(DERM) | 0 | 114,132 | +114,132 | $0 | $643.7K | 0.51% | +$643.7K |
| Beyond Air, Inc.(XAIR) | 903,614 | 903,614 | 0 | $1.57M | $485.5K | 0.38% | -$1.09M |
| Biofrontera Inc.(BFRI) | 504,261 | 504,261 | 0 | $776.6K | $452.8K | 0.36% | -$323.7K |
| Lyra Therapeutics Inc | 1,144,524 | 1,034,773 | -109,751 | $7.12M | $286.3K | 0.23% | -$6.83M |
| Newamsterdam Pharma Co Nv ORDINARY SHARES | 0 | 10,123 | +10,123 | $0 | $194.5K | 0.15% | +$194.5K |
| BioXcel Therapeutics, Inc.(BTAIQ) | 0 | 39,672 | +39,672 | $0 | $50.8K | 0.04% | +$50.8K |
| Tonix Pharma Hldg Crp | 900,900 | 28,154 | -872,746 | $167.6K | $19.6K | 0.02% | -$147.9K |
| Cara Therapeutics Inc | 1,548,893 | 0 | -1,548,893 | $1.41M | $0 | — | -$1.41M |